If you're working out and chasing muscle gains or a lean physique, you may have heard of SARMs . They are often marketed as a “safe” shortcut to build muscle — without the unwanted side-effects of steroids. But are these claims real? Can SARMs truly deliver muscle gains and stay safe? And most importantly — are they legal in 2025? This guide covers everything you need to know in plain, simple language. 🧬 What Are SARMs? SARMs stands for Selective Androgen Receptor Modulators . Wikipedia +1 They are synthetic (laboratory-made) compounds that aim to mimic some effects of male hormones like testosterone. Wikipedia +1 Unlike steroids, SARMs claim to target mostly muscle and bone tissues — not the entire body. Bodybuilding Wizard +1 That’s why they are often marketed as “cleaner” muscle-builders. In short: SARMs are designed to turn on muscle growth machinery — but only in certain tissues. 🔎 Why People Are Drawn to SARMs For many gym-goers, the promise is tempti...
Saatvik Green Energy Ltd. (SGEL) is set to hit the market with a ₹900-crore initial public offering (IPO).
The company has set a price band between ₹442 and ₹465 per equity share and will be issued in lots of 32 equity shares. SGEL plans to raise ₹700 crore in fresh issue and the rest via offer for sale. Originally the company had filed for an IPO size of ₹1,150 crore, with ₹800 crore in fresh issue and ₹300 crore in OFS. The company plans to use the proceeds of the issue to repay borrowings and invest in the 4 GW solar PV module manufacturing facility at Ganjam, Odisha.
This is among many IPOs in the calendar year which had their sizes trimmed, likely due to market conditions. To be sure, IPOs have been late to take-off this in 2025, with the first half of the calendar year having very small number of companies listing.
The bidding is set to open for anchor investors on September 18. The bid will open for other investors on September 19 and will close on September 23.
Comments
Post a Comment